Micafungin Does Not Influence the Concentration of Tacrolimus in Patients After Allogeneic Hematopoietic Stem Cell Transplantation |
| |
Authors: | N. Fukuoka H. Ohnishi Y. Kubota T. Tanaka |
| |
Affiliation: | a Department of Pharmacy, Faculty of Medicine, Kagawa University, Kagawa, Japan b Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan c Department of Laboratory Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan d Department of Transfusion Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan e Environmental Health Sciences, Faculty of Medicine, Kagawa University, Kagawa, Japan |
| |
Abstract: | BackgroundTacrolimus is commonly used in stem cell transplant recipients for prophylaxis of graft-vs-host disease. Micafungin is widely used as a strong antifungal agent in empirical therapy in patients with febrile neutropenia. Both tacrolimus and micafungin are substrates of cytochrome P450 3A4 in vitro. Therefore, there is risk of drug interaction with concomitant administration of these drugs.ObjectiveTo estimate the drug interaction of tacrolimus and micafungin by evaluating the pharmacokinetics in 6 patients who had undergone allogeneic stem cell transplantation.ResultsThe mean (SD) concentration-dose ratio of tacrolimus in all patients at 1, 4, 8, and 24 hours after concomitant administration of micafungin was 607 ± 306, 653 ± 328, 699 ± 340 and 671 ± 403 (ng/mL)/(mg/kg/d), respectively, and without micafungin was 756 ± 314 (ng/mL)/(mg/kg/d). The percentage of the concentration-dose ratio in patients treated with tacrolimus and micafungin vs patients treated with tacrolimus alone was 98%, 105%, 112%, and 108% at 1, 4, 8, and 24 hours, respectively. For both tacrolimus and micafungin, the 90% confidence intervals for the primary pharmacokinetic parameters (ie, the concentration-dose ratio at each point) ranged from 80% to 125%.ConclusionWe conclude that there is no drug interaction between tacrolimus and concomitantly administered micafungin in stem cell transplantation recipients. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|